Scamarin















































































Here's the thing, Vascepa isn't fish oil, so it will dominate this market.

Now as far as Lovaza and Epanova go, they should be very worried.

Read this to make yourself a little smarter:

http://www.frontiersin.org/Cardiac_Electrophysiology/10.3389/fphys.2012.00395/full

Hello, McFly......there is NO PROOF that any of these products will have any beneficial effects on outcomes. Show me any data that cardiovascular events will decrease after taking Vascepa......oh wait, you can't, because it doesn't exist.
 




































Clearly you need NO PROOF, look at fenofibrate sales.

Up to this time, people have assumed that outcomes would improve with a better lipid profile. However, the most recent data is not showing a difference in outcomes.

You bought into the hype and now you are losing what little money you have on this turd of a stock. Deal with it, skippy.